Chikungunya virus E1-E2 glycoprotein complex

The **Chikungunya virus E1-E2 glycoprotein complex** is a heterodimeric assembly found on the viral envelope and is essential for host cell entry and infection. E1 acts as the viral fusion protein, mediating the fusion of viral and host cell membranes, while E2 is responsible for attachment to host cell receptors and contributes the main antigenic sites. Together, these proteins form 80 trimeric spikes (composed of E1-E2 heterodimers) on each virion surface, playing crucial roles in virus-host interaction, immune recognition, and determinants of virulence and host tropism[2][3][5]. E1 contains a fusion loop critical for low-pH–triggered membrane fusion, and E2 mediates attachment to host factors like Mxra8 and cell-surface glycosaminoglycans. Mutations in E1/E2, including at E1 domain II and hinge regions, have been shown to alter virus infectivity, cell attachment, and host adaptation, making these glycoproteins major targets for antiviral drug and vaccine development[1][4][7]. There are currently no licensed drugs or vaccines directly targeting this complex, though several experimental neutralizing antibodies are under development.

Other names

Chikungunya virus envelope glycoproteinsChikungunya E1 and E2 proteinsCHIKV E1/E2Alphavirus E1/E2 glycoprotein (when referring to broader alphaviruses)

Inhibition of fusion (for E1-targeting agents) Blockage of receptor binding and cell entry (for E2-targeting agents and neutralizing antibodies)[4][5] Prevention of conformational changes necessary for membrane fusion